<code id='845867969F'></code><style id='845867969F'></style>
    • <acronym id='845867969F'></acronym>
      <center id='845867969F'><center id='845867969F'><tfoot id='845867969F'></tfoot></center><abbr id='845867969F'><dir id='845867969F'><tfoot id='845867969F'></tfoot><noframes id='845867969F'>

    • <optgroup id='845867969F'><strike id='845867969F'><sup id='845867969F'></sup></strike><code id='845867969F'></code></optgroup>
        1. <b id='845867969F'><label id='845867969F'><select id='845867969F'><dt id='845867969F'><span id='845867969F'></span></dt></select></label></b><u id='845867969F'></u>
          <i id='845867969F'><strike id='845867969F'><tt id='845867969F'><pre id='845867969F'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:994
          AdventHealth alleges in a new lawsuit that MultiPlan conspires with health insurers to keep out-of-network payments low. Adobe

          AdventHealth, a large religious-affiliated hospital system, has sued MultiPlan, alleging the company has worked with health insurers to create a “cartel” that systematically underpays hospitals and doctors for care that is delivered out of an insurance company’s network.

          AdventHealth claims it has “overwhelming direct evidence” that MultiPlan’s agreements with health insurance companies are anticompetitive, and that MultiPlan’s “multi-year, ongoing conspiracy” with insurers has shortchanged hospitals and doctors at least $19 billion per year. MultiPlan said in a statement it “believes this lawsuit has no merit and looks forward to disproving these baseless allegations.”

          advertisement

          The lawsuit pours fresh gasoline on the fraught relationships between hospitals and insurance companies. It also adds to the ongoing debate about how much providers should be paid if they don’t agree to be part of an insurance network.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Food makers to regulators: Ultra
          Food makers to regulators: Ultra

          Foodmakersdon'twantregulatorstofocusonultra-processedfoodswhentheygotoupdatedietaryguidelines.DanKit

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          White House touts steps to stem shortages of cancer treatments

          TheWhiteHouseoutlineditseffortstoendshortagesofthreekeygenericchemotherapies.Butexpertswantmoremored